[
    [
        {
            "time": "",
            "original_text": "创 新 药 研 发 专 题 系 列 ： 小 核 酸 药 物 ： 从 上 游 解 决 疾 病",
            "features": {
                "keywords": [
                    "创新药",
                    "小核酸药物",
                    "研发"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "创 新 药 研 发 专 题 系 列 ： 小 核 酸 药 物 ： 从 上 游 解 决 疾 病",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 4,
                "Duration": 6,
                "Entity_Density": 1,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "医 药 行 业 2 0 2 1 年 三 季 报 总 结 报 告 ： 恢 复 高 成 长 医 药 进 入 估 值 切 换 长 周 期",
            "features": {
                "keywords": [
                    "医药行业",
                    "三季报",
                    "高成长",
                    "估值切换"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医 药 行 业 2 0 2 1 年 三 季 报 总 结 报 告 ： 恢 复 高 成 长 医 药 进 入 估 值 切 换 长 周 期",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 1,
                "Market_Scope": 9,
                "Time_Proximity": 4,
                "Headline_Structure": 6,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "original_text": "凯 莱 英 ( 0 0 2 8 2 1 . S Z ) 拟 回 购 注 销 3 万 股 限 制 性 股 票",
            "features": {
                "keywords": [
                    "凯莱英",
                    "回购注销",
                    "限制性股票"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "凯 莱 英 ( 0 0 2 8 2 1 . S Z ) 拟 回 购 注 销 3 万 股 限 制 性 股 票",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "凯 莱 英 ( 0 0 2 8 2 1 . S Z ) 拟 回 购 注 销 1 0 0 0 股 限 制 性 股 票",
            "features": {
                "keywords": [
                    "凯莱英",
                    "回购注销",
                    "限制性股票"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "凯 莱 英 ( 0 0 2 8 2 1 . S Z ) 拟 回 购 注 销 1 0 0 0 股 限 制 性 股 票",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "凯 莱 英 ( 0 0 2 8 2 1 . S Z ) 2 0 2 0 年 限 制 性 股 票 激 励 计 划 首 次 授 予 部 分 第 一 个 解 除 限 售 期 条 件 成 就",
            "features": {
                "keywords": [
                    "凯莱英",
                    "限制性股票",
                    "激励计划",
                    "解除限售"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "凯 莱 英 ( 0 0 2 8 2 1 . S Z ) 2 0 2 0 年 限 制 性 股 票 激 励 计 划 首 次 授 予 部 分 第 一 个 解 除 限 售 期 条 件 成 就",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "凯 莱 英 ( 0 0 2 8 2 1 . S Z ) ： 3 8 . 9 4 万 股 限 制 性 股 票 可 解 锁",
            "features": {
                "keywords": [
                    "凯莱英",
                    "限制性股票",
                    "解锁"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "凯 莱 英 ( 0 0 2 8 2 1 . S Z ) ： 3 8 . 9 4 万 股 限 制 性 股 票 可 解 锁",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "股 价 5 年 2 0 倍 ！ 手 握 3 1 亿 大 单 ， 千 亿 医 药 巨 头 凯 莱 英 加 速 “ A + H ” 布 局 | IPO 见 闻",
            "features": {
                "keywords": [
                    "凯莱英",
                    "股价增长",
                    "A+H布局",
                    "大单"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "股 价 5 年 2 0 倍 ！ 手 握 3 1 亿 大 单 ， 千 亿 医 药 巨 头 凯 莱 英 加 速 “ A + H ” 布 局 | IPO 见 闻",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 10,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "医 药 健 康 行 业 年 度 策 略 ： 溯 源 而 上 掘 金 创 新",
            "features": {
                "keywords": [
                    "医药健康",
                    "年度策略",
                    "创新"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医 药 健 康 行 业 年 度 策 略 ： 溯 源 而 上 掘 金 创 新",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 1,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "【 行 业 深 度 】 洞 察 2 0 2 1 ： 中 国 肽 C D M O 行 业 竞 争 格 局 及 市 场 份 额 ( 附 市 场 集 中 度 、 企 业 竞 争 力 评 价 等 )",
            "features": {
                "keywords": [
                    "CDMO",
                    "中国肽",
                    "竞争格局",
                    "市场份额"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【 行 业 深 度 】 洞 察 2 0 2 1 ： 中 国 肽 C D M O 行 业 竞 争 格 局 及 市 场 份 额 ( 附 市 场 集 中 度 、 企 业 竞 争 力 评 价 等 )",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "凯 莱 英 涨 超 5 % ， 创 新 药 沪 深 港 E T F （ 5 1 7 1 1 0 ） 涨 超 1 . 5 %",
            "features": {
                "keywords": [
                    "凯莱英",
                    "创新药ETF",
                    "涨幅"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "凯 莱 英 涨 超 5 % ， 创 新 药 沪 深 港 E T F （ 5 1 7 1 1 0 ） 涨 超 1 . 5 %",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 8,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "新 股 速 递 ｜ 凯 莱 英 今 招 股 入 场 费 4 . 1 4 万 元 | 头 条 金 融 网",
            "features": {
                "keywords": [
                    "凯莱英",
                    "新股",
                    "招股",
                    "入场费"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "新 股 速 递 ｜ 凯 莱 英 今 招 股 入 场 费 4 . 1 4 万 元 | 头 条 金 融 网",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        }
    ]
]